Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Exercise or conversion Chief Scientific Officer acquired 76,250 shares (option exercise)
  2. 4 Exercise or conversion Chief Financial Officer acquired 42,347 shares (option exercise)
  3. 4 Exercise or conversion President and CEO acquired 132,679 shares (option exercise)
  4. 4 Open-market sale Chief Scientific Officer sold 383 shares at $12.68 ($4,857)
  5. 4 Open-market sale Chief Financial Officer sold 1,388 shares at $12.66 ($17,568)
  6. 4 Open-market sale President and CEO sold 3,595 shares at $12.66 ($45,513)
  7. 4 Exercise or conversion Chief Scientific Officer acquired 1,050 shares (option exercise)
  8. 4 Exercise or conversion Chief Financial Officer acquired 3,875 shares (option exercise)
  9. 4 Exercise or conversion President and CEO acquired 10,800 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Exercise or conversion Chief Legal Officer acquired 45,518 shares (option exercise)
  13. 4 Gift Director gave 5,500 shares (gift)
  14. 4 Gift Chief Legal Officer gave 7,500 shares (gift)
  15. 4 Other disposition 10% owner disposed of 1,954,904 shares (other)
  16. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,041 shares (to pay taxes)
  17. 4 Open-market sale Chief Medical Officer sold 2,631 shares at $16.98 ($44,675)
  18. 4 Exercise or conversion Chief Medical Officer acquired 6,000 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 21 · 414 filings